» Articles » PMID: 4055166

Mexiletine Action on the Specialized Tissues of the Human Heart

Overview
Specialty Pharmacology
Date 1985 Jan 1
PMID 4055166
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Electrophysiological properties of mexiletine (3 mg/kg i.v.) were studied in fifteen patients with various degrees of abnormalities in the specialized conduction system. Sinus cycle length was decreased in all patients; sinus node recovery time was increased in all patients, but the increment was not statistically significant. Atrial and atrioventricular (AV) nodal refractoriness were not modified. The relative refractory period of the His-Purkinje system was reduced in patients with normal intraventricular conduction on the surface electrocardiogram; no changes were noted in five patients with intraventricular conduction delay. In two patients, in whom AV nodal refractory period curves showed antegrade dual AV nodal pathways, mexiletine increased refractoriness of the fast pathway. This report points out that the drug is effective against arrhythmias sustained by a reentry mechanism, not only in the ventricles, but also in the AV node.

Citing Articles

Characterisation of mexiletine's translational therapeutic index for suppression of ischaemia-induced ventricular fibrillation in the rat isolated heart.

Hesketh L, Wilder C, Ranadive N, Lytra G, Qazimi P, Munro J Sci Rep. 2020; 10(1):8397.

PMID: 32439959 PMC: 7242333. DOI: 10.1038/s41598-020-65190-y.


Mexiletine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias.

Monk J, Brogden R Drugs. 1990; 40(3):374-411.

PMID: 2226221 DOI: 10.2165/00003495-199040030-00005.